Last reviewed · How we verify
active control
Active control is a type of comparator used in clinical trials to compare the efficacy of a new treatment.
Active control is a type of comparator used in clinical trials to compare the efficacy of a new treatment. Used for Various conditions.
At a glance
| Generic name | active control |
|---|---|
| Also known as | Sodium chloride, TECFIDERA® capsules |
| Sponsor | Shanghai SIMR Biotechnology Co., Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Active control is a treatment that is known to be effective for a particular condition, and is used as a reference point to evaluate the effectiveness of a new treatment. This allows researchers to determine whether the new treatment is more or less effective than the existing treatment.
Approved indications
- Various conditions
Common side effects
Key clinical trials
- The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. (NA)
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (PHASE2)
- Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) (PHASE1)
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- The Effect of NP-2006 on Sleep Quality and Health (NA)
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers (PHASE1)
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- active control CI brief — competitive landscape report
- active control updates RSS · CI watch RSS
- Shanghai SIMR Biotechnology Co., Ltd. portfolio CI